KKR Valuation
Is KKRC * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of KKRC * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: KKRC * (MX$2612) is trading above our estimate of fair value (MX$1244.2)
Significantly Below Fair Value: KKRC * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for KKRC *?
Other financial metrics that can be useful for relative valuation.
| What is KKRC *'s n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | US$116.59b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | n/a |
| Enterprise Value/EBITDA | n/a |
| PEG Ratio | 1.5x |
Price to Earnings Ratio vs Peers
How does KKRC *'s PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 51.5x | ||
GPROFUT * Grupo Profuturo. de | 9x | n/a | Mex$27.4b |
BLK BlackRock | 23.2x | 8.2% | US$140.0b |
BN Brookfield | 91x | n/a | CA$111.2b |
ARES Ares Management | 82.8x | 32.9% | US$48.8b |
KKRC * KKR | 30.4x | 20.1% | Mex$116.6b |
Price-To-Earnings vs Peers: KKRC * is good value based on its Price-To-Earnings Ratio (30.4x) compared to the peer average (51.5x).
Price to Earnings Ratio vs Industry
How does KKRC *'s PE Ratio compare vs other companies in the South American Capital Markets Industry?
Price-To-Earnings vs Industry: KKRC * is expensive based on its Price-To-Earnings Ratio (30.4x) compared to the South American Capital Markets industry average (9.2x).
Price to Earnings Ratio vs Fair Ratio
What is KKRC *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 30.4x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate KKRC *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | Mex$2,612.00 | Mex$2,735.93 +4.7% | 10.6% | Mex$3,132.68 | Mex$2,009.64 | n/a | 19 |
| Sep ’25 | n/a | Mex$2,694.98 0% | 11.4% | Mex$3,133.08 | Mex$2,009.90 | n/a | 18 |
| Aug ’25 | Mex$2,306.00 | Mex$2,504.47 +8.6% | 13.5% | Mex$2,984.76 | Mex$1,745.81 | n/a | 17 |
| Jul ’25 | n/a | Mex$2,155.30 0% | 11.6% | Mex$2,883.35 | Mex$1,707.97 | n/a | 17 |
| Jun ’25 | n/a | Mex$1,937.19 0% | 10.1% | Mex$2,470.25 | Mex$1,552.25 | n/a | 17 |
| May ’25 | n/a | Mex$1,971.42 0% | 11.9% | Mex$2,620.74 | Mex$1,446.51 | n/a | 17 |
| Apr ’25 | n/a | Mex$1,799.26 0% | 8.3% | Mex$2,128.83 | Mex$1,413.68 | n/a | 18 |
| Mar ’25 | n/a | Mex$1,820.26 0% | 8.2% | Mex$2,184.52 | Mex$1,450.66 | n/a | 16 |
| Feb ’25 | n/a | Mex$1,615.89 0% | 13.0% | Mex$1,982.15 | Mex$1,085.87 | n/a | 17 |
| Jan ’25 | n/a | Mex$1,424.68 0% | 14.0% | Mex$1,957.14 | Mex$1,081.58 | n/a | 16 |
| Dec ’24 | Mex$1,306.00 | Mex$1,400.77 +7.3% | 10.7% | Mex$1,632.18 | Mex$1,093.91 | n/a | 16 |
| Nov ’24 | n/a | Mex$1,315.91 0% | 8.0% | Mex$1,549.67 | Mex$1,122.17 | n/a | 17 |
| Oct ’24 | n/a | Mex$1,266.75 0% | 10.7% | Mex$1,586.22 | Mex$1,028.43 | n/a | 18 |
| Sep ’24 | n/a | Mex$1,232.42 0% | 10.0% | Mex$1,558.83 | Mex$1,010.67 | n/a | 18 |
| Aug ’24 | n/a | Mex$1,146.08 0% | 10.9% | Mex$1,474.09 | Mex$988.31 | Mex$2,306.00 | 18 |
| Jul ’24 | n/a | Mex$1,129.90 0% | 11.8% | Mex$1,420.30 | Mex$924.05 | n/a | 18 |
| Jun ’24 | n/a | Mex$1,160.82 0% | 11.7% | Mex$1,462.87 | Mex$951.74 | n/a | 18 |
| May ’24 | Mex$927.00 | Mex$1,195.71 +29.0% | 10.6% | Mex$1,461.27 | Mex$1,028.30 | n/a | 18 |
| Apr ’24 | n/a | Mex$1,229.97 0% | 10.9% | Mex$1,458.11 | Mex$1,002.45 | n/a | 17 |
| Mar ’24 | n/a | Mex$1,273.01 0% | 11.2% | Mex$1,502.90 | Mex$1,033.24 | n/a | 16 |
| Feb ’24 | Mex$1,045.00 | Mex$1,208.31 +15.6% | 12.4% | Mex$1,502.74 | Mex$939.21 | n/a | 16 |
| Jan ’24 | Mex$900.00 | Mex$1,256.04 +39.6% | 12.8% | Mex$1,544.81 | Mex$901.14 | n/a | 16 |
| Dec ’23 | n/a | Mex$1,219.32 0% | 11.7% | Mex$1,436.91 | Mex$883.51 | Mex$1,306.00 | 16 |
| Nov ’23 | n/a | Mex$1,231.52 0% | 11.0% | Mex$1,459.27 | Mex$946.56 | n/a | 16 |
| Oct ’23 | Mex$867.00 | Mex$1,362.99 +57.2% | 9.8% | Mex$1,611.08 | Mex$1,168.03 | n/a | 15 |
| Sep ’23 | n/a | Mex$1,367.02 0% | 9.4% | Mex$1,609.50 | Mex$1,166.89 | n/a | 15 |
Analyst Forecast: Target price is less than 20% higher than the current share price.